<HashMap><database>biostudies-literature</database><scores/><additional><submitter>He JY</submitter><funding>Parker Institute for Cancer Immunotherapy</funding><funding>Kenneth Rainin Foundation</funding><funding>Crohn’s and Colitis Foundation</funding><funding>NIDDK NIH HHS</funding><funding>Burroughs Wellcome Fund</funding><funding>NIAID NIH HHS</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>UCSF ImmunoX</funding><funding>V Foundation for Cancer Research</funding><funding>Damon Runyon Cancer Research Foundation</funding><pagination>e008628</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11033653</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(4)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Colitis caused by checkpoint inhibitors (CPI) is frequent and is treated with empiric steroids, but CPI colitis mechanisms in steroid-experienced or refractory disease are unclear.&lt;h4>Methods&lt;/h4>Using colon biopsies and blood from predominantly steroid-experienced CPI colitis patients, we performed multiplexed single-cell transcriptomics and proteomics to nominate contributing populations.&lt;h4>Results&lt;/h4>CPI colitis biopsies showed enrichment of CD4&lt;sup>+&lt;/sup>resident memory (RM) T cells in addition to CD8&lt;sup>+&lt;/sup> RM and cytotoxic CD8&lt;sup>+&lt;/sup> T cells. Matching T cell receptor (TCR) clonotypes suggested that both RMs are progenitors that yield cytotoxic effectors. Activated, CD38&lt;sup>+&lt;/sup> HLA-DR&lt;sup>+&lt;/sup> CD4&lt;sup>+&lt;/sup> RM and cytotoxic CD8&lt;sup>+&lt;/sup> T c</pubmed_abstract><journal>Journal for immunotherapy of cancer</journal><pubmed_title>Dysregulation of CD4&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; and CD8&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; resident memory T, myeloid, and stromal cells in steroid-experienced, checkpoint inhibitor colitis.</pubmed_title><pmcid>PMC11033653</pmcid><funding_grant_id>N/A</funding_grant_id><funding_grant_id>K08AI139375</funding_grant_id><funding_grant_id>K08 DK123202</funding_grant_id><funding_grant_id>T2023-011</funding_grant_id><funding_grant_id>R35 CA253175</funding_grant_id><funding_grant_id>Career Award for Medical Scientists</funding_grant_id><funding_grant_id>CoPilot Award</funding_grant_id><funding_grant_id>CI 110-21</funding_grant_id><funding_grant_id>K08 AI139375</funding_grant_id><funding_grant_id>K08DK123202</funding_grant_id><funding_grant_id>KRA000152</funding_grant_id><funding_grant_id>Career Development Award</funding_grant_id><pubmed_authors>Yang H</pubmed_authors><pubmed_authors>Bain J</pubmed_authors><pubmed_authors>Pisco AO</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Combes AJ</pubmed_authors><pubmed_authors>Fong L</pubmed_authors><pubmed_authors>Shi Y</pubmed_authors><pubmed_authors>Law K</pubmed_authors><pubmed_authors>Fan F</pubmed_authors><pubmed_authors>Mennillo E</pubmed_authors><pubmed_authors>Shen A</pubmed_authors><pubmed_authors>Oh DY</pubmed_authors><pubmed_authors>Davidson B</pubmed_authors><pubmed_authors>He JY</pubmed_authors><pubmed_authors>Kim YJ</pubmed_authors><pubmed_authors>Rao AA</pubmed_authors><pubmed_authors>Kattah MG</pubmed_authors><pubmed_authors>Kushnoor D</pubmed_authors><pubmed_authors>Rusu I</pubmed_authors><pubmed_authors>Cheung A</pubmed_authors><pubmed_authors>Andersen C</pubmed_authors><pubmed_authors>Tsui J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dysregulation of CD4&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; and CD8&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; resident memory T, myeloid, and stromal cells in steroid-experienced, checkpoint inhibitor colitis.</name><description>&lt;h4>Background&lt;/h4>Colitis caused by checkpoint inhibitors (CPI) is frequent and is treated with empiric steroids, but CPI colitis mechanisms in steroid-experienced or refractory disease are unclear.&lt;h4>Methods&lt;/h4>Using colon biopsies and blood from predominantly steroid-experienced CPI colitis patients, we performed multiplexed single-cell transcriptomics and proteomics to nominate contributing populations.&lt;h4>Results&lt;/h4>CPI colitis biopsies showed enrichment of CD4&lt;sup>+&lt;/sup>resident memory (RM) T cells in addition to CD8&lt;sup>+&lt;/sup> RM and cytotoxic CD8&lt;sup>+&lt;/sup> T cells. Matching T cell receptor (TCR) clonotypes suggested that both RMs are progenitors that yield cytotoxic effectors. Activated, CD38&lt;sup>+&lt;/sup> HLA-DR&lt;sup>+&lt;/sup> CD4&lt;sup>+&lt;/sup> RM and cytotoxic CD8&lt;sup>+&lt;/sup> T c</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-06-08T06:04:15.744Z</modification><creation>2026-06-08T03:14:26.326Z</creation></dates><accession>S-EPMC11033653</accession><cross_references><pubmed>38642938</pubmed><doi>10.1136/jitc-2023-008628</doi></cross_references></HashMap>